Skip to main content
Mihran Naljayan, MD, Nephrology, New Orleans, LA

MihranVNaljayanMDMHA

Nephrology • New Orleans, LA

Chief Medical Officer, Home Modalities Group Medical Director- Team Galaxy Clinical Associate Professor of Medicine Section of Nephrology and Hypertension

Join to view full profile

Dr. Naljayan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Naljayan's full profile

Already have an account?

  • Office

    1542 Tulane Ave
    3rd Floor Room 330
    New Orleans, LA 70112
    Phone+1 504-568-8655

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2010 - 2013
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2007 - 2010
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 2007

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License 2010 - 2013
  • SC State Medical License
    SC State Medical License 2013 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Residual Renal Function, Lifestyle Play Key Roles in Incremental Peritoneal Dialysis
    Residual Renal Function, Lifestyle Play Key Roles in Incremental Peritoneal DialysisMarch 16th, 2022
  • DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities
    DaVita Kidney Care Appoints New Chief Medical Officer of Home ModalitiesFebruary 16th, 2022
  • Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout Anyway
    Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout AnywayAugust 11th, 2020
  • Join now to see all

Dr. Mihran Naljayan, Dr. Mihran Naljayan, MD, Dr. M Naljayan, Dr. Mihran V Naljayan